Graphene nanostructures - Theragnostic Technologies
Latest Information Update: 20 Jul 2016
At a glance
- Originator Theragnostic Technologies
- Mechanism of Action Diagnostic imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Burns; Cardiovascular disorders; Fracture; Wounds
Most Recent Events
- 20 Jul 2016 Early research in Burns in USA (Parenteral)
- 20 Jul 2016 Early research in Wounds in USA (Parenteral)
- 20 Jul 2016 Early research in Fracture in USA (Parenteral)